Vittorio Quagliuolo

Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial

Alessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo et al. · The Lancet Oncology · 2017 · 489 citations

Medicine, Oncology, Surgery +17

Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups

Alessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo et al. · Journal of Clinical Oncology · 2020 · 261 citations · Full text

Medicine, Oncology, Pharmacology +17

Distribution of axillary node metastases by level of invasion. An analysis of 539 cases

Umberto Veronesi, Franco Rilke, Alberto Luini et al. · Cancer · 1987 · 232 citations

Medicine, Oncology, Surgery +14

Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the Italian Sarcoma Group and the Spanish Sarcoma Group

Alessandro Gronchi, S. Frustaci, Mario Mercuri et al. · Journal of Clinical Oncology · 2012 · 189 citations

Medicine, Oncology, Surgery +16

The Italian Research Group for Gastric Cancer (GIRCG) guidelines for gastric cancer staging and treatment: 2015

Giovanni De Manzoni, Daniele Marrelli, Gian Luca Baiocchi et al. · Gastric Cancer · 2016 · 188 citations · Full text

Medicine, Oncology, Surgery +16